After completing this course, you will be able to

• Identify the criteria for initiating treatment in COVID-19 outpatients
• Compare and contrast the mechanism of action, pharmacokinetics, pharmacodynamics, efficacy, and safety of the recommended therapies for COVID-19 outpatients
• Recognize and manage common and clinically relevant drug-drug interactions involving COVID-19 therapies and other medications that are used by COVID-19 outpatients
• Apply evidence-based principles and guidelines to select alternative options for COVID-19 treatment when the preferred therapy is not available or appropriate
• Evaluate the benefits and harms of therapies that are of limited or uncertain effect, or not recommended for COVID-19 outpatients
• Adjust drug dosages in the event of interactions, especially for high-risk patients
• Use online tools and interaction checkers to identify and assess drug-drug interactions
• Integrate knowledge from different fields, such as pharmacy, nursing, and infectious disease, to improve patient outcomes
• Identify and navigate potential drug-drug interactions involving nirmatrelvir / ritonavir
• Develop prevention, recognition, and management strategies for drug interactions with nirmatrelvir / ritonavir
• Use the COVID-19 Outpatient Management Handbook, COVID-19 Outpatient Treatment Checklist, and COVID-19 Therapy Selection Flowchart to reinforce understanding and application of strategies for outpatient management of COVID-19